Skip to main content
OpenTrials
Completed

NCT Number: NCT00381979

Supportive Expressive Therapy for Depressed and Anxious Adolescents

The purpose of the study is to investigate the effectiveness of providing Supportive Expressive Therapy to adolescents who are depressed and/or anxious.

Completed

Looking for future studies?

Notify Me

Key information

Age range

15 year–24 year

Sex eligibility

All sexes

Study type

Interventional

Phase

Not applicable

Primary location

Centre for Addiction and Mental Health

Toronto, Ontario, M5T1R8, Canada

About this study

Supportive Expressive Therapy (SET; a 16 session manualized form of psychodynamic therapy) has been well utilized with adult clients. To date, there is no known systematic study into the benefit of this method of therapy with adolescents who are depressed and/or anxious. It is thought that SET would be useful for this population as it is similar in principle to Interpersonal Relationship Therapy (IPT), which has been shown to be effective for use with depressed adults and youth. Both IPT and SET help clients explore the role they play within challenging relationships in their lives. SET, however, allows for the exploration of more relationships within the adolescents' circle. Moreover, SET explores the adolescents' perceptions of themselves, others, and their wish in relationships. Further, the SET method is more easily individualized in that it affords greater flexibility in design and possibility for change over time. Accordingly, the purpose of this study is to explore the feasibility of utilizing this method of therapy with adolescents who are depressed and anxious. We will be exploring the effectiveness of SET through the resolution of depressed and/or anxious adolescents' conflictual relationships thereby reducing their symptomatology.

Who can participate

Healthy volunteers accepted: No

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

  • 15-24 year old, male & female adolescents, primary diagnosis of depression or anxiety disorder.
  • Clients with co-morbid diagnoses, suicidal ideation or taking medication would not necessarily be excluded if deemed able to partake in the proposed therapy.
  • Medication dose needs to be stable for 4-6 weeks prior to starting therapy.

Exclusion criteria

  • Clients who are actively psychotic, developmentally delayed, or have a diagnosis of bipolar disorder.
  • Clients who are not fluent in English.

Treatment and study plan

Supportive Expressive Therapy

Other

Other names: therapy

Primary outcomes

  1. BDI

    Time frame: pre and post

  2. MASC

    Time frame: pre and post

  3. Measures collected at pre, post, and follow-up

    Time frame: pre and post

Secondary outcomes

  1. YSR

    Time frame: pre and post

  2. CBCL

    Time frame: pre and post

  3. FAM

    Time frame: pre and post

  4. CRI

    Time frame: pre and post

  5. SSRS

    Time frame: pre and post

  6. Measures collected at pre, post, and follow-up

    Time frame: pre and post

Sponsors and collaborators

Lead sponsor

Centre for Addiction and Mental Health

Other

Registry information

Important dates

Study start
2004
Primary completion
2007
Study completion
2007
First posted
Sep 28, 2006
Registry last updated
Oct 22, 2015

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.

Published trials that share one or more normalized conditions with this study.